1340. Population Pharmacokinetic (PK) Analysis of APX001 Using Phase 1 Data
Sign Up to like & getrecommendations! Published in 2018 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofy210.1172
Abstract: Abstract Background APX001 is a novel antifungal agent which is rapidly converted to the active metabolite APX001A. APX001A exhibits in vitro activity against many clinically important yeast and fungi, including echinocandin- and azole-resistant Candida species.… read more here.
Keywords: research; apx001; amplyx pharmaceuticals; ppk model ... See more keywords